Immunic, Inc.
IMUX
$0.8522
$0.00320.38%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 7.97% | 31.84% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.96% | 4.66% | |||
| Operating Income | -0.96% | -4.66% | |||
| Income Before Tax | -5.29% | -1.18% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -5.29% | -1.18% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -5.29% | -1.18% | |||
| EBIT | -0.96% | -4.66% | |||
| EBITDA | -0.96% | -4.63% | |||
| EPS Basic | 19.29% | -0.56% | |||
| Normalized Basic EPS | 13.51% | 6.15% | |||
| EPS Diluted | 19.29% | -0.56% | |||
| Normalized Diluted EPS | 13.51% | 6.15% | |||
| Average Basic Shares Outstanding | 30.42% | 0.64% | |||
| Average Diluted Shares Outstanding | 30.42% | 0.64% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||